BackIgene Biotechnology Overview

Igene Biotechnology Common Stock

Igene Biotechnology's common stock is $16M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$15.65M
↑ 0.32% YoYΔ $50000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Igene Biotechnology Common Stock History

Loading

Igene Biotechnology vs. peers: Common Stock Comparison

Loading

Igene Biotechnology Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Igene Biotechnology (IGNE) FAQ

The latest common stock for IGNE is $16M as of September 2010. That compares with $16M in the prior-year period — up 0.3% year over year. Investors often review this figure alongside Igene Biotechnology's historical trend and sector peers before judging valuation or financial health.

Over the past year, IGNE's common stock moved from $16M to $16M — a 0.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Igene Biotechnology's operating scale or balance-sheet position.

A common stock figure of $16M for IGNE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IGNE's common stock ($16M), review year-over-year change from $16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers